| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 07/02/2008 | EP1713447A4 Particulate plant sterol compositions |
| 07/02/2008 | EP1646626B1 Pyrrole-2, 5-dione derivatives as liver x receptor modulators |
| 07/02/2008 | EP1646625B1 Pyrrole-2, 5-dithione derivatives as liver x receptor modulators |
| 07/02/2008 | EP1635791B1 Pharmaceutical compositions comprising atorvastatin manufactured without granulation |
| 07/02/2008 | EP1632233B1 Transfusion preparation for peripheral intravenous administration and method of stabilizing vitamin b1 |
| 07/02/2008 | EP1593666B1 Amino alcohol derivatives, pharmaceutical compositions containing the same, and use thereof |
| 07/02/2008 | EP1501808B1 Tachykinin receptor antagonists |
| 07/02/2008 | EP1496838A4 Substituted amides |
| 07/02/2008 | EP1495019B1 Glucopyranoside, process for isolation thereof, pharmaceutical composition containing same and use thereof |
| 07/02/2008 | EP1474425B9 Deazapurines and uses thereof |
| 07/02/2008 | EP1446022B1 Oilseed processing |
| 07/02/2008 | EP1214287B1 Amides as inhibitors for pyruvate dehydrogenase |
| 07/02/2008 | EP1141003B9 Methods of activation of SGK by phosphorylation. |
| 07/02/2008 | EP1115720B1 Novel n-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them |
| 07/02/2008 | EP0974348B1 Visceral fat lowering agent |
| 07/02/2008 | CN101213281A 新的dha衍生物及其作为药物的用途 Dha new derivatives and their use as medicament |
| 07/02/2008 | CN101213209A Oxyntomodulin analogues and their effects on feeding behaviour |
| 07/02/2008 | CN101213194A Indazoles useful in treating cardiovascular diseases |
| 07/02/2008 | CN101213171A New crystalline atorvastatin hemicalcium salt polymorph form |
| 07/02/2008 | CN101212979A 内脏脂肪蓄积抑制剂 The visceral fat accumulation inhibitor |
| 07/02/2008 | CN101212976A Visceral fat accumulation inhibitor |
| 07/02/2008 | CN101212961A HMB compositions and uses thereof |
| 07/02/2008 | CN101212911A Infant nutrition with hydrolised proteins |
| 07/02/2008 | CN101210255A Recombination ferroportin adenovirus, preparation method and application thereof |
| 07/02/2008 | CN101210012A Novel isoflavone nicotinic acid ester derivatives, preparing method and use thereof |
| 07/02/2008 | CN101210011A Quinolines compounds and their intermediates, preparation method and application |
| 07/02/2008 | CN101210009A Bruguiesulfurol, derivatives and preparation method thereof, and application for the same in preparing diabetes treatment medicament |
| 07/02/2008 | CN101209975A Levulorotation carnitine calcium fumarate and its preparing method and use |
| 07/02/2008 | CN101209336A Compound essential oil for fat-reducing |
| 07/02/2008 | CN101209284A Method for continuously extracting alkaloids, flavone and polysaccharide active components from mulberry leaves |
| 07/02/2008 | CN101209273A Preparation of inula japonica total polysaccharide and its application in defaecation and expelling toxin |
| 07/02/2008 | CN101209257A Medical use of baicalin and scutellarein derivatives |
| 07/02/2008 | CN101209256A Polydatin medicinal composition containing polyvinyl pyrrolidone |
| 07/02/2008 | CN101209100A Ca-enriched flavouring and its manufacturing method |
| 07/02/2008 | CN101209094A Spinach strawberry gel and preparation method thereof |
| 07/02/2008 | CN101209093A Aloe apple gel and preparation method thereof |
| 07/02/2008 | CN101209092A Carrot sugarcane gel and preparation method thereof |
| 07/02/2008 | CN101209091A Aloe pineapple gel and preparation method thereof |
| 07/02/2008 | CN101209090A Lettuce pawpaw gel and preparation method thereof |
| 07/02/2008 | CN101209085A Feed capable of reducing body fat and mortality rate of chicken and breeding method therewith |
| 07/02/2008 | CN101209084A Pet beverage containing active peptide and preparation method thereof |
| 07/02/2008 | CN101209066A Various grains í«saqimaí» |
| 07/02/2008 | CN100398544C Aqueous triptolide alcohol derivative with high immunesuppressive activity and its application |
| 07/02/2008 | CN100398541C Pyrimidinone derivatives and 3-keto ester |
| 07/02/2008 | CN100398537C Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals |
| 07/02/2008 | CN100398535C Piperidine derivatives and their use as modulators of chemokine receptor activity especially CCR5 |
| 07/02/2008 | CN100398533C Substituted 3-cyanothiophene acetamides as glucagon receptor antagonists |
| 07/02/2008 | CN100398526C 3-methyl-2- (3- (2-phenyl-oxazol-4-ylmethoxy)-cyclohexanecarbonyl-amino butyric acid derivatives and related compounds as ppar modulators for the treatment of type 2 diabetes and atherosclerosis |
| 07/02/2008 | CN100398519C Tetracyclic benzamide derivatives and methods of use thereof |
| 07/02/2008 | CN100398148C Nutrient and healthy capsule of active ass hide |
| 07/02/2008 | CN100398123C Medicine for treating diabetes of blood stasis complicated kidney spleen deficiency type |
| 07/02/2008 | CN100398121C Application of picrorhiza rhizome in preparation of medicine for treating diabetes |
| 07/02/2008 | CN100398114C Composition of stachyose and bee product |
| 07/02/2008 | CN100398112C Medicine for treating hyperphosphatemia and its preparing method |
| 07/02/2008 | CN100398105C 1,3-substitued cycloalkyl derivatives having acidic, mostly heterocyclic groups, processes for their preparation and their use as pharmaceuticals |
| 07/02/2008 | CN100398003C Sanitary battercake of ginseng |
| 07/01/2008 | US7393875 Reducing islet amyloid polypeptide (IAPP) associated deposit; type II diabetes |
| 07/01/2008 | US7393849 N-[4-Amidinobenzoyl]-N-[3-phenoxybenzyl]-3-(4-biphenyl)-alanyl-glycyl-amide; anticarcinogenic, antidiabetic, anticholesterol agent, cardiovascular disorders, osteoporosis |
| 07/01/2008 | US7393842 Pyrazole analogs acting on cannabinoid receptors |
| 07/01/2008 | US7393838 Glucopyranosyloxypyrazole derivatives and use thereof in medicines |
| 07/01/2008 | US7393655 Nucleotide sequences coding cyclic peptide receptor for use in identifying modulators for treatment of pituitary hormone, epinephrine release, gastrointestinal, cardiovascular, electrolyte balance, hypertensive, diabetic and respiratory system disorder |
| 07/01/2008 | US7393551 Denatured carob flour (DCF) with a low content of soluble tannins and sugars, meant for human consumption and process to obtain it |
| 07/01/2008 | US7393545 Lipstatin derivative—soluble fiber tablets |
| 06/26/2008 | WO2008077050A1 Adenosine derivatives as partial and full agonists of a1 adenosine receptors |
| 06/26/2008 | WO2008076810A2 Azabicyclic heterocycles as cannabinoid receptor modulators |
| 06/26/2008 | WO2008075949A1 Modulation of human microsomal triglyceride transfer protein (mtp or mttp) gene expression by food-grade/ingested dietary microorganisms |
| 06/26/2008 | WO2008075741A1 Therapeutic agent and prophylactic agent for diabetes |
| 06/26/2008 | WO2008075736A1 Method for producing c-glycoside derivative and synthetic intermediate thereof |
| 06/26/2008 | WO2008075621A1 Antacid |
| 06/26/2008 | WO2008075528A1 Use of h. macrophylla tea |
| 06/26/2008 | WO2008075077A1 Piperidine derivatives for the treatment of obesity |
| 06/26/2008 | WO2008075073A1 Novel crystalline compound useful as glk activator |
| 06/26/2008 | WO2008075070A1 Sulfonamide derivatives for therapeutic use as fatty acid synthase inhibitors |
| 06/26/2008 | WO2008075019A1 Modulators of cb1 receptors |
| 06/26/2008 | WO2008075013A1 Modulators of cannabinoid receptor |
| 06/26/2008 | WO2008075012A1 Cb1 receptor modulators |
| 06/26/2008 | WO2008074982A1 Pyrazole derivatives as modulators of cannabinoid receptor |
| 06/26/2008 | WO2008074935A2 Biologically active compositions, methods for producing the same and biological applications |
| 06/26/2008 | WO2008074834A2 Isoquinolinecarboxamides as inhibitors of stearoyl-coa desaturase (scd) |
| 06/26/2008 | WO2008074833A2 Compounds |
| 06/26/2008 | WO2008074832A2 Isoquinolinecarboxamides as inhibitors of stearoyl-coa desaturase ( scd) |
| 06/26/2008 | WO2008074824A2 Isoquinolinecarboxamides as inhibitors of stearoyl-coa desaturase (scd) |
| 06/26/2008 | WO2008074723A1 Inclusion complex of ezetimibe and a cyclodextrin and processes in the preparation thereof |
| 06/26/2008 | WO2008074694A1 Crystallization of glucokinase activators |
| 06/26/2008 | WO2008074692A1 Sulfonamide derivatives as liver carnitine palmitoyl transferase (l-cptl ) |
| 06/26/2008 | WO2008074656A1 Process for harvesting plants of the apocynaceae family |
| 06/26/2008 | WO2008036387A8 Method of treating endothelial dysfunction |
| 06/26/2008 | WO2008021851A3 Novel compounds as antagonists or inverse agonists for opioid receptors |
| 06/26/2008 | WO2007073175A3 Composition comprising polyunsaturated fatty acids for improving membrane composition |
| 06/26/2008 | US20080153899 Fatty amine drug conjugates |
| 06/26/2008 | US20080153893 Pyrazole Carboxamides as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase-1 |
| 06/26/2008 | US20080153889 Derivatives of 11-nonyloxy-undec-8(Z)-eonic acid, e.g., (Z)- 6-amino-2-(11-(nonyloxy)undec-8-enamido)hexanoic acid; compounds mimic epoxide metabolites; for use in treatment of renal or cardiovascular disease; hypotensive agents |
| 06/26/2008 | US20080153857 Specific capsaicin receptor modulators; analgesics; neuropathic pain; obesity; antitussives, hiccups; e.g. (4-Cyclopropyl-phenyl)-[2-methoxymethyl-7-(3-trifluoromethyl-pyridin-2-yl)-quinazolin-4-yl]-amine |
| 06/26/2008 | US20080153843 Bradykinin 1 receptor (B1R) antagonists for treating various inflammatory diseases, pain, obesity; compounds bind to both rat and human receptors for pharmacological testing; ether and amide-functional N-heterocycle sulfonamides |
| 06/26/2008 | US20080153837 4-(Benzimidazol-2-yl)fluorene and 4-(azabenzimidazol-2-yl)fluorene derivatives; treating disorders related to Hsp90 protein; anticarcinogenic, antimetastasis, antitumor, anticoagulant, antiproliferative, antihistamine, and antidiabetic agents; metabolic, muscular, rheumatic and nervous system disorders |
| 06/26/2008 | US20080153831 prevention and treatment of osteoporosis are provided herein. The compositions contain one or more isoflavones, such as genistein and derivatives thereof, in combination with one or more folates, such as a reduced folate and/or folic acid; and/or one or more polyunsaturated fatty acids (PUFAs), |
| 06/26/2008 | US20080153821 Nitrogen-containing 5-membered ring compound |
| 06/26/2008 | US20080153810 novel indazole that may be used as melanin concentrating hormone receptor ligands, methods of preparing such compounds, compositions containing such compounds, and methods of using such compounds to treat MCH related disorders. |
| 06/26/2008 | US20080153807 fused 1,2,4-triazoles for modulating the activity of 11 beta -hydroxysteroid dehydrogenase type 1 (11 beta HSD1) and the use of these compounds as pharmaceutical compositions has been described. Also a novel class of fused 1,2,4-triazoles, their use in therapy, pharmaceutical compositions |
| 06/26/2008 | US20080153806 diagnostic test and method is provided comprising mixing blood or another biological fluid sample with a test compound and spotting the blood on filter paper for subsequent analysis of the effect of the test compound on the blood. The biological fluid can be a cerebrospinal |